753 related articles for article (PubMed ID: 34610144)
1. Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave.
Fong D; Mair MJ; Lanthaler F; Alber M; Mitterer M
Int J Cancer; 2022 Feb; 150(3):431-439. PubMed ID: 34610144
[TBL] [Abstract][Full Text] [Related]
2. Associations of Government-Mandated Closures and Restrictions With Aggregate Mobility Trends and SARS-CoV-2 Infections in Nigeria.
Erim DO; Oke GA; Adisa AO; Odukoya O; Ayo-Yusuf OA; Erim TN; Tsafa TN; Meremikwu MM; Agaku IT
JAMA Netw Open; 2021 Jan; 4(1):e2032101. PubMed ID: 33471117
[TBL] [Abstract][Full Text] [Related]
3. Detection of severe acute respiratory syndrome coronavirus 2 in nasopharynx according to clinical phenotype of affected patients.
Valent F; Di Chiara A
Clin Microbiol Infect; 2020 Dec; 26(12):1686.e1-1686.e4. PubMed ID: 32905833
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
5. Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April-May 2020: implications for policy and practice.
Tang S; Sanchez Perez M; Saavedra-Campos M; Paranthaman K; Myers R; Fok J; Crawley-Boevey E; Dun-Campbell K; Janarthanan R; Fernandez E; Vusirikala A; Patel B; Ma T; Amin-Chowdhury Z; Shetty N; Zambon M; Bell A; Wynne-Evans E; Chow Y; Ladhani S
Age Ageing; 2021 May; 50(3):649-656. PubMed ID: 33620453
[TBL] [Abstract][Full Text] [Related]
6. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
Letizia AG; Ramos I; Obla A; Goforth C; Weir DL; Ge Y; Bamman MM; Dutta J; Ellis E; Estrella L; George MC; Gonzalez-Reiche AS; Graham WD; van de Guchte A; Gutierrez R; Jones F; Kalomoiri A; Lizewski R; Lizewski S; Marayag J; Marjanovic N; Millar EV; Nair VD; Nudelman G; Nunez E; Pike BL; Porter C; Regeimbal J; Rirak S; Santa Ana E; Sealfon RSG; Sebra R; Simons MP; Soares-Schanoski A; Sugiharto V; Termini M; Vangeti S; Williams C; Troyanskaya OG; van Bakel H; Sealfon SC
N Engl J Med; 2020 Dec; 383(25):2407-2416. PubMed ID: 33176093
[TBL] [Abstract][Full Text] [Related]
8. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium.
Heireman L; Abrams S; Bruynseels P; Cartuyvels R; Cuypers L; De Schouwer P; Laffut W; Lagrou K; Hens N; Ho E; Padalko E; Reynders M; Vandamme S; Van der Moeren N; Verstrepen W; Willems P; Naesens R
PLoS One; 2021; 16(11):e0259908. PubMed ID: 34762704
[TBL] [Abstract][Full Text] [Related]
10. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.
Leuzinger K; Gosert R; Søgaard KK; Naegele K; Bielicki J; Roloff T; Bingisser R; Nickel CH; Khanna N; Sutter ST; Widmer AF; Rentsch K; Pargger H; Siegemund M; Stolz D; Tamm M; Bassetti S; Osthoff M; Battegay M; Egli A; Hirsch HH
J Med Virol; 2021 Apr; 93(4):2374-2384. PubMed ID: 33314153
[TBL] [Abstract][Full Text] [Related]
12. Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.
Bird PW; Sandhu K; Fletcher O; Ames B; Toovey O; Tang JW
J Med Virol; 2021 Oct; 93(10):6050-6053. PubMed ID: 34173993
[TBL] [Abstract][Full Text] [Related]
13. Could masks curtail the post-lockdown resurgence of COVID-19 in the US?
Ngonghala CN; Iboi EA; Gumel AB
Math Biosci; 2020 Nov; 329():108452. PubMed ID: 32818515
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period.
Srichatrapimuk S; Chookajorn T; Kochakarn T; Kirdlarp S; Pasomsub E; Chantratita W; Iamsirithaworn S; Kunakorn M; Thitithanyanont A; Sungkanuparph S; Phuphuakrat A
Travel Med Infect Dis; 2022; 46():102271. PubMed ID: 35123068
[TBL] [Abstract][Full Text] [Related]
15. Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020.
McGovern OL; Stenger M; Oliver SE; Anderson TC; Isenhour C; Mauldin MR; Williams N; Griggs E; Bogere T; Edens C; Curns AT; Lively JY; Zhou Y; Xu S; Diaz MH; Waller JL; Clarke KR; Evans ME; Hesse EM; Morris SB; McClung RP; Cooley LA; Logan N; Boyd AT; Taylor AW; Bajema KL; Lindstrom S; Elkins CA; Jones C; Hall AJ; Graitcer S; Oster AM; Fry AM; Fischer M; Conklin L; Gokhale RH
PLoS One; 2021; 16(4):e0249901. PubMed ID: 33857209
[TBL] [Abstract][Full Text] [Related]
16. First Wave of COVID-19 Pandemic in Italy: Data and Evidence.
Bezzini D; Schiavetti I; Manacorda T; Franzone G; Battaglia MA
Adv Exp Med Biol; 2021; 1353():91-113. PubMed ID: 35137370
[TBL] [Abstract][Full Text] [Related]
17. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
18. Development of a web-based contact tracing and point-of-care-testing workflow for SARS-CoV-2 at a German University Hospital.
Zirbes J; Sterr CM; Steller M; Dapper L; Nonnenmacher-Winter C; Günther F
Antimicrob Resist Infect Control; 2021 Jul; 10(1):102. PubMed ID: 34215330
[TBL] [Abstract][Full Text] [Related]
19. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics Associated with Return Visits to the Emergency Department after COVID-19 Diagnosis.
Husain I; O'Neill J; Mudge R; Bishop A; Soltany KA; Heinen J; Countryman C; Casey D; Cline D
West J Emerg Med; 2021 Nov; 22(6):1257-1261. PubMed ID: 34787548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
